Online Activities
SnapShot
From Comprehensive Patient Evaluations to Individualized Evidence-Based Care
Finding the Way Forward
A Two-Part Continuing Medical Education Series on the Evolving Models of HIV Care
The Increasing Role of JAK Inhibitors
Monograph
A PEP/PrEP Training Guide for Pharmacists
POC201
International
Webcast
Unlocking Novel Paths to Patient Care
Webcast
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
POC201
Evolving Best Practices for Patient Management
eHealthSource
Early Diagnosis to Ongoing Collaborative Care
Webcast
Benefits, Barriers, & Best Practices in an Advancing Field
SnapShot
Pathophysiology, Multimodal Management, and Shared Clinical Decision Making
POC101
Information You Need to Keep Your Practice Up to Date
POC101
Maximizing Your Role to Impact Patient Outcomes
Webcast
Optimizing Sexual Health and Decreasing HIV Risk
Webcast
An Online and Mobile Mini-Curriculum
Webcast Series
Modules 1-3
POC101
A Foundation for Managed Care
eHealthSource
A PrEP Primer
SnapShot
From Patient Identification to Collaborative Long-term Care
Webcast
New Paths to Chronic Pain Management
Webcast
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyps
Monograph
Preventing HIV Infection in the Pharmacy Setting
Webcast
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
POC101
Best Practices for Primary Care
POC101
The Clinical and Utilization Benefits of Exacerbation Prevention
Shared Decision-making in the Era of Biologics
Archived Activities
Mechanistic Insights and Emerging Treatment Options
Unpacking the Evidence for Their Use Today and Tomorrow
Digging Deep on Shared Decision-Making
Looking Beyond Hemoglobin A1c
Translating Guidelines Into Patient Care
A Case-Based Look at Exacerbation Prevention
A Guide to Healthcare Advances for Specialist Clinicians
Debates and Discussions About Managing Moderate-to-Severe Disease
Catch up with experts on the latest evidence related to HIV prevention, rapid-start antiretroviral (ART) therapy, and HCV screening and treatment for people who inject drugs—the population at highest risk of transmission. These 15-minute expert interviews will provide the epidemiologic trends that underlie the imperative for HIV preexposure prophylaxis (PrEP), present HIV treatment as prevention (TasP), and emphasize the feasibility, efficacy, and ease of treating HCV-infected PWID.
This series of 3 unique, case-based, interactive online activities was developed to improve the care of patients with HIV. The instructional design incorporates the latest evidence-based guidelines for HIV management into clinical scenarios of different patient populations. Case topics cover treatment initiation, rapid antiretroviral therapy (ART) protocols, considerations for people with substance use, switching regimens for simplification or comorbidities, and treatment and adherence in transgender patients.
Implications for PCSK9 Inhibitors in Clinical Practice
Interdisciplinary Management of Patients With Severe Asthma
Optimizing Management Strategies in Moderate-to-Severe Atopic Dermatitis
Physicians need further education to fully understand and implement current advanced therapies and distinguish the pathways of disease and targets addressed by newer therapies. This educational activity will provide key clinical data on new and emerging treatments, focusing on the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway in the context of evolving understanding of disease immunopathogenesis.
Mechanistic Insights and Evolving Treatment Options
This educational activity will address the pharmacist’s critical role in HCV elimination, guideline-based HCV testing and identification of persons at risk, harm-reduction–informed patient education, and selected models for effective linkage to HCV treatment.
Debates & Discussions on the Evolving Role of JAK Inhibitors
Collaborative Care for Better Patient Outcomes
HIV as a Chronic Disease: A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
Debates and Discussions Around Cardiovascular and Renal Outcomes
